These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 18307285)

  • 1. Modulation of antibody pharmacokinetics by chemical polysialylation.
    Constantinou A; Epenetos AA; Hreczuk-Hirst D; Jain S; Deonarain MP
    Bioconjug Chem; 2008 Mar; 19(3):643-50. PubMed ID: 18307285
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Site-specific polysialylation of an antitumor single-chain Fv fragment.
    Constantinou A; Epenetos AA; Hreczuk-Hirst D; Jain S; Wright M; Chester KA; Deonarain MP
    Bioconjug Chem; 2009 May; 20(5):924-31. PubMed ID: 19402707
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of ricin A chain conjugates of monoclonal antibodies to human alpha-fetoprotein and placental alkaline phosphatase on antigen-producing tumor cells in culture.
    Tsukazaki K; Hayman EG; Ruoslahti E
    Cancer Res; 1985 Apr; 45(4):1834-8. PubMed ID: 2579736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reagents for astatination of biomolecules. 2. Conjugation of anionic boron cage pendant groups to a protein provides a method for direct labeling that is stable to in vivo deastatination.
    Wilbur DS; Chyan MK; Hamlin DK; Vessella RL; Wedge TJ; Hawthorne MF
    Bioconjug Chem; 2007; 18(4):1226-40. PubMed ID: 17583925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conversion of murine antibodies to human antibodies and their optimization for ovarian cancer therapy targeted to the folate receptor.
    Figini M; Martin F; Ferri R; Luison E; Ripamonti E; Zacchetti A; Mortarino M; Di Cioccio V; Maurizi G; Allegretti M; Canevari S
    Cancer Immunol Immunother; 2009 Apr; 58(4):531-46. PubMed ID: 18704410
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antitumor effect of lidamycin-containing monoclonal antibody immunoconjugate with downsized-molecule].
    Liu XY; Zhen YS
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2001 Dec; 23(6):563-7. PubMed ID: 12901099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted delivery of anti-CD19 liposomal doxorubicin in B-cell lymphoma: a comparison of whole monoclonal antibody, Fab' fragments and single chain Fv.
    Cheng WW; Allen TM
    J Control Release; 2008 Feb; 126(1):50-8. PubMed ID: 18068849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Radioimmunotherapy with 131 I-labeled humanized anti-HBsAg Fab and anti-nucleus antigen monoclonal antibody chTNT in nude mice bearing human hepatocellular carcinoma].
    DU YF; Luo RC; Li GP; Li AM; Ding XM; Yan X; Huang K
    Nan Fang Yi Ke Da Xue Xue Bao; 2008 Mar; 28(3):460-2. PubMed ID: 18359714
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional humanization of an anti-CD16 Fab fragment: obstacles of switching from murine {lambda} to human {lambda} or {kappa} light chains.
    Schlapschy M; Fogarasi M; Gruber H; Gresch O; Schäfer C; Aguib Y; Skerra A
    Protein Eng Des Sel; 2009 Mar; 22(3):175-88. PubMed ID: 19022801
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improvement of biodistribution and therapeutic index via increase of polyethylene glycol on drug-carrying liposomes in an HT-29/luc xenografted mouse model.
    Chow TH; Lin YY; Hwang JJ; Wang HE; Tseng YL; Wang SJ; Liu RS; Lin WJ; Yang CS; Ting G
    Anticancer Res; 2009 Jun; 29(6):2111-20. PubMed ID: 19528471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conversion of a mouse Fab into a whole humanized IgG antibody for detecting botulinum toxin.
    Palys TJ; Schmid KE; Scherer JM; Schoepp RJ
    Hum Antibodies; 2006; 15(4):125-32. PubMed ID: 17522434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor immunolocalization using monoclonal antibodies which bind placental alkaline phosphatase.
    Jemmerson R; Takeya M; Shah N; Fishman WH
    Prog Clin Biol Res; 1984; 166():245-56. PubMed ID: 6504930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycoengineering approach to half-life extension of recombinant biotherapeutics.
    Chen C; Constantinou A; Chester KA; Vyas B; Canis K; Haslam SM; Dell A; Epenetos AA; Deonarain MP
    Bioconjug Chem; 2012 Aug; 23(8):1524-33. PubMed ID: 22681552
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary antibody-Fab fragment complexes: a flexible alternative to traditional direct and indirect immunolabeling techniques.
    Brown JK; Pemberton AD; Wright SH; Miller HR
    J Histochem Cytochem; 2004 Sep; 52(9):1219-30. PubMed ID: 15314089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. PEGylation of antibody fragments for half-life extension.
    Jevševar S; Kusterle M; Kenig M
    Methods Mol Biol; 2012; 901():233-46. PubMed ID: 22723105
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of an enzyme-linked immunosorbent assay to study the disposition of sheep digoxin-specific immunoglobulin G and Fab fragments in the rat.
    Johnston PC; Stevenson IH; Hewick DS
    Clin Exp Immunol; 1988 Dec; 74(3):489-93. PubMed ID: 3233793
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative antibody Fab' fragment PEGylation strategies: combination of strong reducing agents, disruption of the interchain disulphide bond and disulphide engineering.
    Humphreys DP; Heywood SP; Henry A; Ait-Lhadj L; Antoniw P; Palframan R; Greenslade KJ; Carrington B; Reeks DG; Bowering LC; West S; Brand HA
    Protein Eng Des Sel; 2007 May; 20(5):227-34. PubMed ID: 17452434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibition of the growth of hepatoma and hepatic metastasis by pingyangmycin conjugated with Fab' fragment of monoclonal antibody].
    Liu X; Shang B; Liu X
    Zhonghua Yi Xue Za Zhi; 2001 Feb; 81(4):201-4. PubMed ID: 11798873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polysialic acids: potential in improving the stability and pharmacokinetics of proteins and other therapeutics.
    Gregoriadis G; Fernandes A; Mital M; McCormack B
    Cell Mol Life Sci; 2000 Dec; 57(13-14):1964-9. PubMed ID: 11215521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Disulfide bond bridged divalent antibody-toxin, (Fab-PE38fl)2, with the toxin PE38 fused to the light chain.
    Won J; Choe M
    J Microbiol Biotechnol; 2008 Aug; 18(8):1475-81. PubMed ID: 18756111
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.